This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Horizon Therapeutics USA, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Paul Michael Peloso: Inventor in Gout Treatment
Introduction
Paul Michael Peloso is an inventor associated with Naples, Florida, and Horizon Therapeutics USA, Inc. His patent work concerns approaches to treating gout with PEGylated uricase.
Latest Patents
Peloso is named on 1 patent, titled “Methods of Treating Gout.” The disclosure describes administering PEGylated uricase through an infusion lasting less than 120 minutes and using an infusion volume below 250 mL. It also describes co-administering PEGylated uricase with methotrexate (MTX), with the aim of reducing immunogenicity and prolonging the urate-lowering effect.
Career Highlights
Peloso’s listed company affiliation is Horizon Therapeutics USA, Inc. His patent reflects research into infusion protocols and combination treatment strategies for gout.
Collaborations
Swarnendra K. Verma is identified as Peloso’s coworker. The patent information provided describes approaches involving PEGylated uricase and MTX.
Conclusion
Paul Michael Peloso’s patent work focuses on potential ways to administer PEGylated uricase and combine it with MTX in gout treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile